Expanded Access to Risankizumab
NCT03914261
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Crohn's Disease
Ulcerative Colitis (UC)
Interventions
DRUG:
Risankizumab
Sponsor
AbbVie